Recent Finacing
Recent Raise
River 2 Renal develops therapies for orphan kidney diseases by in-licensing deprioritized pharmaceutical molecules for redevelopment, operating under Narrow River management and collaborating with biotech investors.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors